- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03264417
Pulmonary Function Test Study - Automated Interpretation
Study Overview
Status
Conditions
Detailed Description
This is a multi-center non-interventional retrospective study that will use data obtained from clinical routine. In the hospital, subjects with or without respiratory complaints undergo subset of (or complete) pulmonary function tests if clinically indicated. Results of these tests, expressed as numerical values are send to the clinical workstation (KWS) for immediate clinical use. These results are subsequently being interpreted by a clinician.
A random sample of 50 lung function printouts of subjects followed at the Leuven pulmonary service with a final diagnosis of a respiratory disease have been randomised. These anonymized printouts will be given to different pulmonologists for examination in 18 different centers and compared with the interpretation of in-house developed software.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Leuven, Belgium, 3000
- UZ Leuven
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age more than 18 years
- Completed one or more pulmonary function tests
Exclusion Criteria:
- Younger than 18
- Lung transplantation, lung cancer.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interclass correlation coëfficiënt for whole group
Time Frame: 6 months
|
Variation in preferred primary diagnosis of respiratory disease given by every physician for every case (selection of one diagnosis out of a fixed panel of 9 possible diagnoses).
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interclass correlation coëfficiënt for every case
Time Frame: 6 months
|
Variation in preferred primary diagnosis of respiratory disease given by every physician for an individual case (selection of one diagnosis out of a fixed panel of 9 possible diagnoses).
|
6 months
|
|
Accuracy of physicians expressed as a percentage of correct diagnoses per case (%)
Time Frame: 6 months
|
Comparison of diagnostic labels per case provided by the physicians with gold standard diagnosis based on clinical characteristics, complete pulmonary function test data and all other investigations (CT scan, biochmestry, functional test, biopsy, etc...) needed to come to a gold standard diagnosis.
|
6 months
|
|
Accuracy of physicans expressed as a percentage of correct diagnoses in total group (%)
Time Frame: 6 months
|
Comparison of diagnostic labels per case provided by the physicians with gold standard diagnosis based on clinical characteristics, complete pulmonary function test data and all other investigations (CT scan, biochmestry, functional test, biopsy, etc...) needed to come to a gold standard diagnosis.
|
6 months
|
|
Accuracy of physicians expressed as a percentage of correct diagnoses per hospital (group) (%)
Time Frame: 6 months
|
Comparison of diagnostic labels per case provided by the group of physicians per hospital with gold standard diagnosis based on clinical characteristics, complete pulmonary function test data and all other investigations (CT scan, biochmestry, functional test, biopsy, etc...) needed to come to a gold standard diagnosis.
|
6 months
|
|
Accuracy of software expressed as a percentage of correct diagnoses in total group, per hospital and per case
Time Frame: 6 months
|
Comparing labels of in-house developed software for the clinical interpretation and diagnostic labeling of complete pulmonary function tests with GOLD standard based on all additional tests
|
6 months
|
|
Comparison of accuracy (% of correct diagnoses) of physicians with software
Time Frame: 6 months
|
Comparing the diagnostic labels provided by in-house developed software for the clinical interpretation and diagnostic labeling of complete pulmonary function tests with those of physicans (in total group, per hospital and per case)
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Wim Janssens, Prof. Dr., UZ Leuven
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S60619
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Disease
-
Altesa Biosciences, Inc.CompletedHealthy | Pulmonary Disease | COPD | Respiratory Disease | Lower Respiratory DiseaseUnited States
-
Altesa Biosciences, Inc.Virtus Respiratory ResearchCompletedRCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory InfectionInfections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases | Lung Diseases | Pulmonary Disease, Chronic Obstructive | Enterovirus Infections | Copd | Pulmonary Disease | Respiratory Disease | Respiratory Complication | Upper Respiratory Tract Infections | Respiratory Viral Infection | ... and other conditionsUnited Kingdom
-
FisioRespiraciónUniversidad Complutense de Madrid; NeumomadridUnknownAcute Disease RespiratorySpain
-
Società Italiana di Allergologia, Asma e Immunologia...Società Italiana di Allergologia e Immunologia Pediatrica (SIAIP)Recruiting
-
Rochester General HospitalCompletedAspirin-exacerbated Respiratory DiseaseUnited States
-
SOS Oxygene MediterraneeRecruitingExercise | Chronic Respiratory DiseaseFrance
-
Larissa University HospitalRecruitingRespiratory Disease (Clinically Stable Individuals - Patients Recovered From Respiratory Disease)Greece
-
University Hospital, LimogesCompletedCOPD | Chronic Respiratory DiseaseFrance
-
Insel Gruppe AG, University Hospital BernRecruitingChronic Respiratory DiseaseSwitzerland
-
West Park Healthcare CentreEnrolling by invitation